Viewing StudyNCT00004110



Ignite Creation Date: 2024-05-05 @ 10:01 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004110
Status: COMPLETED
Last Update Posted: 2013-10-31
First Post: 1999-12-10

Brief Title: Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Organization Data

Organization: Memorial Sloan Kettering Cancer Center
Class: OTHER
Study ID: MSKCC-IRB-99033
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH